Caricamento...
Health Canada's Proposal to Accelerate New Drug Reviews
Health Canada is proposing to update its accelerated review pathways to get important new drugs into the market more quickly. To date, the two pathways that Health Canada uses have not demonstrated that they can identify therapeutically valuable new drugs. Drugs approved under the two pathways also...
Salvato in:
| Pubblicato in: | Healthc Policy |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Longwoods Publishing
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7294445/ https://ncbi.nlm.nih.gov/pubmed/32538346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12927/hcpol.2020.26227 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|